Author:
Cerea G.,Ricotta R.,Schiavetto I.,Maugeri M.R.,Sartore-Bianchi A.,Moroni M.,Artale S.,Siena S.
Reference11 articles.
1. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC CancerBase no. 5, version 2.0;Ferlay,2004
2. Systemic therapy for colorectal cancer;Meyerhardt;N Engl J Med,2005
3. Targeting the epidermal growth factor receptor for cancer therapy;Mendelsohn;J Clin Oncol,2002
4. Cetuximab (IMC-C225) plus irinotecan (CPT-11) is active in CPT-11 refractory colorectal cancer that expresses epidermal growth factor receptor;Saltz;Prog Proc Am Soc Clin Oncol,2001
5. Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor;Saltz;J Clin Oncol,2004
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献